Sotera Health(NASDAQ) SHC

Sotera Health Company helps keep medical products safe by killing germs. It works with hospitals to ensure tools are ready to use. These services protect patients and meet health laws.

What Keeps Healthcare Safe?

• Sterigenics: Sterilization services using gas and radiation to kill germs on medical tools; recorded $211.6 million in net revenue for the three months ended June 30, 2026.
• Nordion: Supply of Cobalt-60, a radioactive material used for sterilization and cancer treatments; recorded $49.1 million in net revenue for the three months ended June 30, 2026.
• Nelson Labs: Microbiological testing and advisory services to ensure medicines and devices are safe; recorded $60.7 million in net revenue for the three months ended June 30, 2026.

Recent Strategic Moves

• Entered Amendment No. 7 to the Credit Agreement on May 20, 2026, to refinance and reprice $1.4 billion in term loans.
• Issued $750.0 million in aggregate principal amount of secured notes on May 30, 2024, to manage long-term debt.
• Paid a $34.0 million settlement in Feb. 2026 for litigation related to ethylene oxide claims in Illinois.
• Increased capital spending to $92.6 million for the six months ended June 30, 2026, for facility and cobalt development projects.

How the Company Stands Out

Sotera Health is the only vertically integrated global provider of gamma sterilization because it produces its own supply of Cobalt-60, a radioactive material used to kill bacteria. This integration means the company manages both the material supply and the final sterilization service for its customers. The firm supports the entire product lifecycle for medical manufacturers by offering both terminal sterilization and specialized laboratory testing.

Performance by the Numbers

• Total net revenues were $321.4 million for the three months ended June 30, 2026, up 9.2% year over year.
• Net income was $53.6 million for the three-month period ended June 30, 2026, up 573.7% year over year.
• Adjusted EBITDA reached $165.7 million for the three months ended June 30, 2026, a 10.0% increase year over year.
• Cash and cash equivalents stood at $356.7 million as of June 30, 2026.

Bottom Line

Sotera Health has built a vertically integrated model that secures its supply of materials for sterilization. Its focus on regulatory compliance and testing services makes it a core partner for global healthcare manufacturers.